Patents by Inventor Chester Kuei

Chester Kuei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and methods for generating repair scripts that facilitate remediation of malware side-effects
    Patent number: 9659176
    Abstract: The disclosed computer-implemented method for generating repair scripts that facilitate remediation of malware side-effects may include (1) identifying a potentially malicious file located on a computing system, (2) determining at least one potential side-effect of the potentially malicious file, (3) generating, based at least in part on the potential side-effect of the potentially malicious file, a repair script that facilitates remediation of the potential side-effect, and then (4) remedying the potential side-effect by directing the computing system to execute the repair script. Various other methods, systems, and computer-readable media are also disclosed.
    Type: Grant
    Filed: July 17, 2014
    Date of Patent: May 23, 2017
    Assignee: Symantec Corporation
    Inventors: Michele Roter, Chester Kuei
  • PHYSIOLOGICAL LIGANDS FOR GPR139
    Publication number: 20160022636
    Abstract: Provided herein are compounds capable of activating GPR139. Also provided are methods of increasing and decreasing the activity of GPR139. Methods of using the identified compounds to modulate GPR139 activity or conditions that may be affected by GPR139 activity are also disclosed.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 28, 2016
    Inventors: Curt A. DVORAK, Changlu LIU, Chester KUEI
  • PHYSIOLOGICAL LIGANDS FOR GPR139
    Publication number: 20140336216
    Abstract: Provided herein are compounds capable of activating GPR139. Also provided are methods of increasing and decreasing the activity of GPR139. Methods of using the identified compounds to modulate GPR139 activity or conditions that may be affected by GPR139 activity are also disclosed.
    Type: Application
    Filed: March 14, 2014
    Publication date: November 13, 2014
    Applicant: Janssen Pharmaceutica NV
    Inventors: Curt A. Dvorak, Changlu Liu, Chester Kuei
  • Chimeric peptide antagonist for GPCR135 or GPCR142
    Patent number: 8299028
    Abstract: The chimeric polypeptide R3(B?23-27)R/I5 is described, which is a high-affinity antagonist for GPCR1 35 and GPCR1 42 over LGR7.
    Type: Grant
    Filed: January 23, 2008
    Date of Patent: October 30, 2012
    Assignee: Janssen Pharmaceutica NV
    Inventors: Chester Kuei, Changlu Liu, Cindy M. Pudiak, Jonathan Edward Shelton, Steven W. Sutton
  • Relaxin-3 chimeric polypeptides and their preparation and use
    Patent number: 7893197
    Abstract: Chimeric polypeptides of relaxin-3, prepropolypeptides thereof, polynucleotides encoding such polypeptides, and associated expression vectors and host cells are described. The polypeptides may be used to prepare receptor-ligand complexes with GPCR135 or GPCR142, which may be used in assay methods.
    Type: Grant
    Filed: August 25, 2005
    Date of Patent: February 22, 2011
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Pascal Bonaventure, Chester Kuei, Changlu Liu, Timothy W. Lovenberg, Steven W. Sutton
  • CHIMERIC PEPTIDE ANTAGONIST FOR GPCR135 OR GPCR142
    Publication number: 20100145007
    Abstract: The chimeric polypeptide R3(B?23-27)R/I5 is described, which is a high-affinity antagonist for GPCR1 35 and GPCR1 42 over LGR7.
    Type: Application
    Filed: January 23, 2008
    Publication date: June 10, 2010
    Inventors: Chester Kuei, Changlu Liu, Cindy M. Pudiak, Jonathan Shelton, Steven W. Sutton
  • Relaxin-3 Chimeric Polypeptides and Their Preparation and Use
    Publication number: 20080051336
    Abstract: Chimeric polypeptides of relaxin-3, prepropolypeptides thereof, polynucleotides encoding such polypeptides, and associated expression vectors and host cells are described. The polypeptides may be used to prepare receptor-ligand complexes with GPCR135 or GPCR142, which may be used in assay methods.
    Type: Application
    Filed: August 25, 2005
    Publication date: February 28, 2008
    Inventors: Pascal Bonaventure, Chester Kuei, Changlu Liu, Timothy Lovenberg, Steven Sutton
  • Relaxin3-gpcr135 complexes and their production and use
    Publication number: 20060188956
    Abstract: A GPCR135/relaxin3 complex is described, which is useful as an assay reagent for screening for modulators of GPCR135 receptor activity.
    Type: Application
    Filed: February 25, 2004
    Publication date: August 24, 2006
    Inventors: Jingcai Chen, Chester Kuei, Changlu Liu, Timothy Lovenberg, Rannar Sillard, Steven Sutton
  • Relaxin3-GPCR135 complexes and their production and use
    Publication number: 20050074814
    Abstract: A GPCR135/relaxin3 complex is described, which is useful as an assay reagent for screening for modulators of GPCR135 receptor activity.
    Type: Application
    Filed: February 25, 2004
    Publication date: April 7, 2005
    Inventors: Jingcai Chen, Chester Kuei, Changlu Liu, Timothy Lovenberg, Rannar Sillard, Steven Sutton
  • Complexes of GPCR142 and relaxin3 or INSL5, and their production and use
    Publication number: 20050059089
    Abstract: A GPCR142/relaxin3 and GPCR142/INSL5 complexes are described. The complexes are useful as assay reagents for screening for modulators of GPCR142 receptor activity.
    Type: Application
    Filed: August 6, 2004
    Publication date: March 17, 2005
    Inventors: Chester Kuei, Changlu Liu, Timothy Lovenberg, Steven Sutton, Jingcai Chen